5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Alzheimer’s disease (AD) is a progressive, neurodegenerative dementia with no cure. Prominent hypotheses suggest accumulation of beta-amyloid (Aβ) contributes to neurodegeneration and memory loss, however identifying brain regions with early susceptibility to Aβ remains elusive. Using SWITCH to immunolabel intact brain, we created a spatiotemporal map of Aβ deposition in the 5XFAD mouse. We report that subcortical memory structures show primary susceptibility to Aβ and that aggregates develop in increasingly complex networks with age. The densest early Aβ occurs in the mammillary body, septum, and subiculum- core regions of the Papez memory circuit. Previously, early mammillary body dysfunction in AD had not been established. We also show that Aβ in the mammillary body correlates with neuronal hyper-excitability and that modulation using a pharmacogenetic approach reduces Aβ deposition. Our data demonstrate large-tissue volume processing techniques can enhance biological discovery and suggest that subcortical susceptibility may underlie early brain alterations in AD.

          Abstract

          Rebecca Canter et al. use the SWITCH technique for immunolabeling whole brain to show that core regions of the Papez memory circuit are susceptible to Aβ accumulation in mice. They find that Aβ accumulation in the mammillary body is linked to neuronal hyper-excitability and amyloid deposition can be reduced using a pharmacogenetics approach.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Gamma frequency entrainment attenuates amyloid load and modifies microglia.

          Changes in gamma oscillations (20-50 Hz) have been observed in several neurological disorders. However, the relationship between gamma oscillations and cellular pathologies is unclear. Here we show reduced, behaviourally driven gamma oscillations before the onset of plaque formation or cognitive decline in a mouse model of Alzheimer's disease. Optogenetically driving fast-spiking parvalbumin-positive (FS-PV)-interneurons at gamma (40 Hz), but not other frequencies, reduces levels of amyloid-β (Aβ)1-40 and Aβ 1-42 isoforms. Gene expression profiling revealed induction of genes associated with morphological transformation of microglia, and histological analysis confirmed increased microglia co-localization with Aβ. Subsequently, we designed a non-invasive 40 Hz light-flickering regime that reduced Aβ1-40 and Aβ1-42 levels in the visual cortex of pre-depositing mice and mitigated plaque load in aged, depositing mice. Our findings uncover a previously unappreciated function of gamma rhythms in recruiting both neuronal and glial responses to attenuate Alzheimer's-disease-associated pathology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Single-cell phenotyping within transparent intact tissue through whole-body clearing.

            Understanding the structure-function relationships at cellular, circuit, and organ-wide scale requires 3D anatomical and phenotypical maps, currently unavailable for many organs across species. At the root of this knowledge gap is the absence of a method that enables whole-organ imaging. Herein, we present techniques for tissue clearing in which whole organs and bodies are rendered macromolecule-permeable and optically transparent, thereby exposing their cellular structure with intact connectivity. We describe PACT (passive clarity technique), a protocol for passive tissue clearing and immunostaining of intact organs; RIMS (refractive index matching solution), a mounting media for imaging thick tissue; and PARS (perfusion-assisted agent release in situ), a method for whole-body clearing and immunolabeling. We show that in rodents PACT, RIMS, and PARS are compatible with endogenous-fluorescence, immunohistochemistry, RNA single-molecule FISH, long-term storage, and microscopy with cellular and subcellular resolution. These methods are applicable for high-resolution, high-content mapping and phenotyping of normal and pathological elements within intact organs and bodies. Copyright © 2014 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

              To determine whether the presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to familial Alzheimer's disease (FAD) increase the extracellular concentration of amyloid beta-protein (A beta) ending at A beta 42(43) in vivo, we performed a blinded comparison of plasma A beta levels in carriers of these mutations and controls. A beta 1-42(43) was elevated in plasma from subjects with FAD-linked PS1 (P < 0.0001), PS2N1411 (P = 0.009), APPK670N,M671L (P < 0.0001), and APPV7171 (one subject) mutations. A beta ending at A beta 42(43) was also significantly elevated in fibroblast media from subjects with PS1 (P < 0.0001) or PS2 (P = 0.03) mutations. These findings indicate that the FAD-linked mutations may all cause Alzhelmer's disease by increasing the extracellular concentration of A beta 42(43), thereby fostering cerebral deposition of this highly amyloidogenic peptide.
                Bookmark

                Author and article information

                Contributors
                idelalle@bu.edu
                khchung@mit.edu
                lhtsai@mit.edu
                Journal
                Commun Biol
                Commun Biol
                Communications Biology
                Nature Publishing Group UK (London )
                2399-3642
                4 October 2019
                4 October 2019
                2019
                : 2
                : 360
                Affiliations
                [1 ]ISNI 0000 0001 2341 2786, GRID grid.116068.8, The Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, , Massachusetts Institute of Technology, ; Cambridge, MA USA
                [2 ]ISNI 0000 0001 2341 2786, GRID grid.116068.8, Institute for Medial Engineering and Science (IMES), MIT, ; Cambridge, MA USA
                [3 ]ISNI 0000 0001 0705 3621, GRID grid.240684.c, Rush Alzheimer’s Disease Center, , Rush University Medical Center, ; Chicago, IL USA
                [4 ]ISNI 0000 0004 0367 5222, GRID grid.475010.7, Department of Pathology and Laboratory Medicine, , Boston University School of Medicine, ; Boston, MA USA
                [5 ]ISNI 0000 0001 2341 2786, GRID grid.116068.8, Department of Chemical Engineering, , MIT, ; Cambridge, MA USA
                Author information
                http://orcid.org/0000-0003-3681-7410
                http://orcid.org/0000-0002-8167-3340
                Article
                599
                10.1038/s42003-019-0599-8
                6778135
                31602409
                89a60fa4-dd81-419d-8b18-d8ec4a7cba10
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 5 June 2019
                : 4 September 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000049, U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging);
                Award ID: RF1AG047661
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/100000002, U.S. Department of Health & Human Services | National Institutes of Health (NIH);
                Award ID: 1-U01-NS090473-01
                Award ID: P30AG10161
                Award ID: RF1AG15819
                Award Recipient :
                Funded by: JPB Foundation Norman B. leventhal and Barbara Weedon fellowship Burroughs Wellcome Fund, Career awards at the scientific interface Searle Scholars program, Packard award in science and engineering NARSAD, young investigator award NCSOFT cultural foundation
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                alzheimer's disease,neural circuits
                alzheimer's disease, neural circuits

                Comments

                Comment on this article